Established the 「Sino Cell Stem Cell Cryopreservation Center」 at the Bioresource Collection and Research Center (BCRC) of the FIRDI.
The research and development project 「Analytic System for the ex vivo Expansion of Hematopoietic Stem Cells」 was granted Small Business Innovation Research (SBIR) funding by the Ministry of Economic Affairs.
The 「Serum-free culture and Directed Differentiation of Umbilical Cord Blood-Derived Mesenchymal Stem Cells」 was granted SBIR funding by the Ministry of Economic Affairs.
The first institution in Taiwan to introduce the Taylor-Wharton’s LABS-80K large LN2 storage system.
The 「HSC ex vivo Expansion Technology」 was awarded international patent application number.
National Innovation Award was granted to the self-developed 「Portable Thermostatic Transporting Box for Umbilical Cord Blood.」
Collaborated with the medical teams from CGMH and NTUH to complete Taiwan’s first case on 「Treatment of Cerebral Palsy with Autologous Umbilical Cord Blood.」
Collaborated with the Taipei Medical University on 「The Establishment for Preservation and Quality Control Technology of Umbilical Cord and Amniotic Derived Mesenchymal Stem Cells.」
Signed a contract with the National Yang Ming University and become Taiwan’s first UCB stem cell company to be authorized for the patented cell culture technology for 「Umbilical Cord Mesenchymal Stem Cells.」
Industry-academic collaboration with the Yuan Ze University on the development of 「Isolation and ex vivo Expansion of Vascular Endothelial Precursor Cells in Umbilical Cord Blood.」
Combined with the SinoPac Life Insurance Agent Co. and Cathay Life Insurance to offer Taiwan’s first 「Health Insurance for Umbilical Cord Blood Transplantation (UCBT).」
Created the 「Peripheral Blood Stem Cell Bank」 and was audited and authorized by the Ministry of Health and Welfare to comply with the Regulations for Administration on Human Organ Bank.
Received exclusive U.S. Patent for 「Serum-free Culture Medium」; Patent Number US 8762074 B2.
Sino Cell Technologies, Ltd. (SCT) became the member bank of Cord Blood Association (CBA), the only entity from Taiwan. CBA member banks include Cord Blood Registry (CBR, the No.1 family bank in the US), PerkinElmer Viacord, New York Blood Center, StemCell Institute, Inc (Tokyo, Japan) and other family and public banks from all over the world. Incumbent president is Dr. Joanne Kurtzberg, an internationally renowned expert in umbilical cord blood banking and transplantation from Duke University, School of Medicine. As a member of CBA, SCT has proved its technology in line with global standards. In the future, SCT will work with CBA closely in cord blood innovations, products, technologies, market expansion and services.